TickerTalks
Browse all tickers →
TickerTalks›$NHC
NHNHC

National HealthCare Corporation

$NHC·$3.5B·Medical - Care Facilities·Healthcare
$224.47-0.2%YTD+64.4%1Y+94.6%
Price updated 2d ago·X counts updated 1d ago
NHNHC
$NHCNational HealthCare Corporation
$224.47-0.20%14 posts
AI analysisFundamentalsVoices on X
Loading…

On X

The complete picture of $NHC on X — how loud the conversation is right now, how it has trended over the last two weeks, and which way the crowd is leaning.

14X posts · last 7 days
Sep 3Sep 12

AI verdictAI analysisGenerated by AI from underlying data

TickerTalks' own read on what's driving $NHC — fundamentals, momentum, or an event — and whether it agrees with the X crowd.

Proven numbersCooling offAI verdict · as of 2026-09-12

Catching its breath after a run — could pick back up or fade from here.

National HealthCare is +94% over twelve months on skilled-nursing tailwinds — but the CEO and Chief Medical Officer keep trimming.

The insider tape (Flatt Aug 25 and Aug 28, Gifford Aug 25) is the clear signal here: multiple executives selling into strength after a doubled stock.

  • Shares +64.4% YTD and +94.6% over twelve months at PE ~24.9 and PS ~2.25 — a re-rate from post-COVID lows into the current elevated-occupancy environment.
  • Connor Clark & Lunn's Aug 30 new position is the institutional side of the tape.
  • Aug 30 "unusually high trading volume" note picks up the churn — probably retail chasing the run.
  • The Aug 30 hurricane-cyclone headlines are national-hurricane-center references, ticker-symbol overlap noise.

Cooling because the insider distribution is meaningful and the multiple has caught up to peer-leader levels; Nov 6 Q3 print is where occupancy, labor cost, and Medicaid-rate commentary determines the next leg.

What to watch: Watch the Nov 6 Q3 print for skilled-nursing-facility occupancy, wage-inflation trajectory, and Medicaid-rate-update commentary — a strong quarter with contained labor costs breaks cooling.

On the calendar: 2026-11-06 Q3 earnings

insider sellingcashtag hijack risk

Read the AI verdict on $NHC

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • Whether TickerTalks' read agrees with or diverges from the X crowd
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

National HealthCare Corporation (NHC) is a prominent provider in the healthcare sector, involved in the operation, management, and service provision for a wide array of elder care and health facilities. Its diverse portfolio includes skilled nursing facilities, assisted living communities, independent living residences, homecare and hospice agencies, and a specialized behavioral health hospital. Within its skilled nursing environments, NHC offers extensive therapeutic and medical care. Patients recovering from conditions such as strokes, heart attacks, orthopedic injuries, neurological ailments, or other illnesses and disabilities benefit from licensed physical, speech, respiratory, and occupational therapies. These facilities also provide essential services like nutritional guidance, social support, recreational activities, and daily necessities such as housekeeping and laundry, all complemented by physician-prescribed medical treatments. Distinctive medical specialty units further enhance care, featuring memory care for individuals with Alzheimer's and similar disorders, alongside sub-acute nursing units. NHC's assisted living centers are designed to offer personal support, helping residents with everyday tasks including dressing, bathing, meal preparation, and medication management. The company also addresses mental well-being through behavioral health services for both adults and geriatric patients, treating psychiatric, emotional, and addictive conditions. Beyond direct facility care, NHC delivers additional healthcare programs, incorporating skilled services like infusion, wound care, and advanced physical, occupational, and speech therapies. Its offerings extend to hospice care, the operation of pharmacies, and a suite of corporate services encompassing management, accounting, financial, and insurance solutions. Furthermore, NHC engages in leasing its properties to third-party operators. As of February 18, 2022, NHC's operational footprint was substantial, comprising 75 skilled nursing facilities with a capacity of 9,473 beds, 24 assisted living facilities, 5 independent living facilities, one behavioral health hospital, 34 homecare agencies, and 28 hospice agencies. Founded in 1971, National HealthCare Corporation is headquartered in Murfreesboro, Tennessee.

Industry overviewAI analysisGenerated by AI from underlying data

Where Medical - Care Facilities sits in its cycle right now — and what that implies for $NHC.

Medical - Care Facilities · Healthcare

Hospital and care-facility volumes have normalised with payer-mix shift back toward commercially insured; AI-administrative tools are improving hospital operating efficiency. Medicaid redetermination headwinds and labour-cost pressure are the key risks.

Top industry ETF

$IHFiShares U.S. Healthcare Providers ETF
+17.9%YTD
+15.3%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
24.9How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
7.3%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
9.3%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
4.2%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
2.3Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
12.9%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
39.5%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.0Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q2 2026Aug 6, 2026$2.54——
Q1 2026May 8, 2026$1.91——
Q4 2025Feb 26, 2026$1.83——
Q3 2025Nov 7, 2025$1.58——
Next earningsFri, Nov 6

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q2 FY26$408.0M+8.8%40.7%12.0%$2.58$30.7M
Q1 FY26$381.8M+2.2%38.4%8.4%$2.31$52.9M
Q4 FY25$386.5M+4.6%39.7%8.6%$1.61$6.4M
Q3 FY25$382.7M+12.5%39.1%7.9%$2.53$56.5M

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.5×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.88%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.+1.1%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.+26.0%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatLow float · 12.7M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.4% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β0.635-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

Insider activity

Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.

Recent transactions

SellAug 28Flatt Ben Anderson SrSenior VP & CIO1.0K sh$223KSellAug 25Flatt Ben Anderson SrSenior VP & CIO1.0K sh$227KSellAug 25David R. GiffordDirector1.8K sh$401KSellAug 20Flatt Ben Anderson SrSenior VP & CIO1.0K sh$237KSellAug 19Flatt Ben Anderson SrSenior VP & CIO1.0K sh$237KSellAug 19Flatt Stephen FowlerCEO1.5K sh$356KSellAug 17Flatt Ben Anderson SrSenior VP & CIO1.0K sh$226KSellAug 14Flatt Ben Anderson SrSenior VP & CIO1.0K sh$222KSellAug 12Flatt Ben Anderson SrSenior VP & CIO1.0K sh$221KSellJun 22Emil E HassanDirector5.9K sh$1.2M
1–10 of 14
+ 24 other (10 awards · 8 exempts · 3 gifts · 3 inkinds) in window

See when $NHC insiders are putting their own money in

  • Real-time open-market buys and sells from Form 4 filings
  • Cluster-buy detection when multiple insiders pile in at once
  • 30 / 60 / 180-day windows so you can spot building conviction
Free, forever. No credit card.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

Recent material filings

8-KAcquisition completedJul 18-K — Item 1.01: Material agreement · Item 1.02: Agreement terminated · Item 2.01: Acquisition completed · Item 2.03: Material debt obligation · Item 7.01: Press release / Reg FD
8-KAgreement terminatedMay 278-K — Item 1.01: Material agreement · Item 1.02: Agreement terminated · Item 2.03: Material debt obligation
8-KMaterial agreementMay 158-K — Item 1.01: Material agreement
8-KShareholder voteMay 138-K — Item 5.07: Shareholder vote
8-KAgreement terminatedApr 228-K — Item 1.01: Material agreement · Item 1.02: Agreement terminated · Item 7.01: Press release / Reg FD
+ 11 other (3 13Gs · 2 routine 8-Ks · 2 earnings 8-Ks · 2 10-Qs) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

NHC says 50% chance of cyclone formation in next 48 hours off Louisiana coastreuters.com·14d agoConnor Clark & Lunn Investment Management Ltd. Purchases New Position in National HealthCare Corporation $NHCdefenseworld.net·15d agoNational HealthCare (NYSEAMERICAN:NHC) Sees Unusually-High Trading Volume – What’s Next?defenseworld.net·15d agoBlackRock Inc. Takes $417.60 Million Position in National HealthCare Corporation $NHCdefenseworld.net·19d agoNHC Reports Second Quarter 2026 Earningsbusinesswire.com·38d ago

More in Medical - Care Facilities

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$HIMS$THC$NUTX$AVAH$STLN$CON$ASTH$PNTG
Voices on X · last 7 days

No standout posts about $NHC on X in the last 7 days.

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport